A complementary new drug for PNH

被引：7
作者：
Brodsky, Robert A. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
来源：
BLOOD | 2020年 / 135卷 / 12期
关键词：
D O I：
10.1182/blood.2020004959
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Roth et al show in a phase 1/2 trial that crovalimab, a subcutaneously administered monoclonal antibody that targets C5, is safe and effective in treating paroxysmal nocturnal hemoglobinuria (PNH).(1) Crovalimab targets a C5 epitope that is different from the IV C5 inhibitors, eculizumab and ravulizumab. Crovalimab is administered subcutaneously every 4 weeks.
引用
收藏
页码：884 / 885
页数：3
相关论文
共 9 条
  • [1] Characterization of breakthrough hemolysis events observed in the phase III randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria
    Brodsky, Robert A.
    de latour, Regis Peffault
    Rottinghaus, Scott T.
    Roeth, Alexander
    Risitano, Antonio M.
    Weitz, Ilene C.
    Hillmen, Peter
    Maciejewski, Jaroslaw P.
    Szer, Jeff
    Lee, Jong Wook
    Kulasekararaj, Austin G.
    Volles, Lori
    Damokosh, Andrew I.
    Ortiz, Stephan
    Shafner, Lori
    Liu, Peng
    Hillc, Anita
    Schrezenmeier, Hubert
    [J]. HAEMATOLOGICA, 2021, 106 (01) : 230 - 237
  • [2] Paroxysmal nocturnal haemoglobinuria
    Hill, Anita
    DeZern, Amy E.
    Kinoshita, Taroh
    Brodsky, Robert A.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2017, 3
  • [3] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) : 1233 - 1243
  • [4] Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
    Kelly, Richard J.
    Hill, Anita
    Arnold, Louise M.
    Brooksbank, Gemma L.
    Richards, Stephen J.
    Cullen, Matthew
    Mitchell, Lindsay D.
    Cohen, Dena R.
    Gregory, Walter M.
    Hillmen, Peter
    [J]. BLOOD, 2011, 117 (25) : 6786 - 6792
  • [5] Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
    Lee, Jong Wook
    de Fontbrune, Flore Sicre
    Lee, Lily Wong Lee
    Pessoa, Viviani
    Gualandro, Sandra
    Fuereder, Wolfgang
    Ptushkin, Vadim
    Rottinghaus, Scott T.
    Volles, Lori
    Shafner, Lori
    Aguzzi, Rasha
    Pradhan, Rajendra
    Schrezenmeier, Hubert
    Hill, Anita
    [J]. BLOOD, 2019, 133 (06) : 530 - 539
  • [6] Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays
    Moyo, VM
    Mukhina, GL
    Garrett, ES
    Brodsky, RA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (01) : 133 - 138
  • [7] Genetic Variants in C5 and Poor Response to Eculizumab
    Nishimura, Jun-ichi
    Yamamoto, Masaki
    Hayashi, Shin
    Ohyashiki, Kazuma
    Ando, Kiyoshi
    Brodsky, Andres L.
    Noji, Hideyoshi
    Kitamura, Kunio
    Eto, Tetsuya
    Takahashi, Toru
    Masuko, Masayoshi
    Matsumoto, Takuro
    Wano, Yuji
    Shichishima, Tsutomu
    Shibayama, Hirohiko
    Hase, Masakazu
    Li, Lan
    Johnson, Krista
    Lazarowski, Alberto
    Tamburini, Paul
    Inazawa, Johji
    Kinoshita, Taroh
    Kanakura, Yuzuru
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (07) : 632 - 639
  • [8] Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab
    Risitano, Antonio M.
    Notaro, Rosario
    Marando, Ludovica
    Serio, Bianca
    Ranaldi, Danilo
    Seneca, Elisa
    Ricci, Patrizia
    Alfinito, Fiorella
    Camera, Andrea
    Gianfaldoni, Giacomo
    Amendola, Angela
    Boschetti, Carla
    Di Bona, Eros
    Fratellanza, Giorgio
    Barbano, Filippo
    Rodeghiero, Francesco
    Zanella, Alberto
    Iori, Anna Paola
    Selleri, Carmine
    Luzzatto, Lucio
    Rotoli, Bruno
    [J]. BLOOD, 2009, 113 (17) : 4094 - 4100
  • [9] The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria
    Roeth, Alexander
    Nishimura, Jun-ichi
    Nagy, Zsolt
    Gaal-Weisinger, Julia
    Panse, Jens
    Yoon, Sung-Soo
    Egyed, Miklos
    Ichikawa, Satoshi
    Ito, Yoshikazu
    Kim, Jin Seok
    Ninomiya, Haruhiko
    Schrezenmeier, Hubert
    Sica, Simona
    Usuki, Kensuke
    de Fontbrune, Flore Sicre
    Soret, Juliette
    Sostelly, Alexandre
    Higginson, James
    Dieckmann, Andreas
    Gentile, Brittany
    Anzures-Cabrera, Judith
    Shinomiya, Kenji
    Jordan, Gregor
    Biedzka-Sarek, Marta
    Klughammer, Barbara
    Jahreis, Angelika
    Bucher, Christoph
    de Latour, Regis Peffault
    [J]. BLOOD, 2020, 135 (12) : 912 - 920
1